Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Astria Therapeutics, Inc. (ATXS)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   10-K10-K10-K10-K/A10-K10-K10-K10-K
Net income  -51.8-219.3-37.3-26.3-25.9-27.4-36.1-32.6
Depreciation and amortization      0.10.30.40.2
Stock-based compensation  4.63.41.4 1.82.02.21.7
Change in working capital   [+]2.1-3.23.2-1.80.8-1.90.30.7
Other operating activities  1.7189.00.21.5-0.30.20.40.3
Cash from operations  -43.5-30.2-32.5-26.6-23.5-26.8-32.9-29.8
   
Capital expenditures   [+]-0.10.00.00.00.0-0.1-0.5-0.4
Purchases of short-term investments, net  -167.0-19.06.3-4.1-22.314.9-15.1 
Other cash from investing   6.5      
Cash from investing  -167.1-12.66.3-4.1-21.914.9-15.5-0.4
   
Issuance of common stock, net  107.6104.324.618.538.9 10.661.7
Option exercises  0.10.00.00.10.00.00.50.1
Financing costs         0.0
Other cash from financing  37.20.016.37.25.44.7-0.916.7
Cash from financing  144.7104.340.925.644.34.79.278.3
   
Free cash flow  -43.6-30.2-32.5-26.6-23.5-26.9-33.3-30.2
        Per share (diluted)  ($2.98)($3.38)($10.63)($2.37)($4.64)($12.40)($2.05)($3.76)
   
Cash paid for interest      0.10.30.60.7

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy